# Novocure Ltd (NVCR)

> Healthcare · CH · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NVCR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 357.64M | $ -86.80M | $ -13.14M | $ 233.42M | $ 338.09M |
| 2025 | $ 671.02M | $ -139.48M | $ -77.49M | $ 290.00M | $ 340.47M |
| 2024 | $ 636.13M | $ -177.24M | $ -72.76M | $ 683.35M | $ 360.18M |
| 2023 | $ 550.72M | $ -223.87M | $ -108.59M | $ 596.24M | $ 362.50M |
| 2022 | $ 600.82M | $ -103.37M | $ 10.53M | $ 584.27M | $ 441.17M |
| 2021 | $ 635.97M | $ -69.36M | $ 69.64M | $ 581.90M | $ 410.49M |
| 2020 | $ 629.79M | $ 25.23M | $ 107.24M | $ 450.68M | $ 476.53M |
| 2019 | $ 453.46M | $ -9.33M | $ 20.83M | $ 168.20M | $ 217.79M |
| 2018 | $ 327.62M | $ -83.94M | $ -11.33M | $ 149.27M | $ 112.26M |
| 2017 | $ 238.48M | $ -83.07M | $ -54.56M | $ 97.34M | $ 113.56M |
| 2016 | $ 114.04M | $ -181.40M | $ -172.33M | $ 96.23M | $ 142.35M |
| 2015 | $ 46.46M | $ -156.66M | $ -154.66M | $ 23.10M | $ 250.82M |
| 2014 | $ 21.89M | $ -114.00M | $ -108.18M | $ 321.0K | $ 97.88M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.69 |
| Liabilities / Eq | 1.35 |
| Current Ratio | 2.89 |

## Other views

- [Metrics](https://sponda.capital/en/NVCR.md)
- [Charts](https://sponda.capital/en/NVCR/charts.md)
- [Compare](https://sponda.capital/en/NVCR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.
